Perioperative medicine & outcomes

Retrospective Analysis of the Association of Preoperative Sex Hormone Therapy With the Development of Postoperative Acute Kidney Injury

Anesth AnalgPublished Retrospective cohort study

Authors' conclusion

Preoperative antiandrogen therapy in men and vaginal estrogen therapy in women older than 55 years were associated with reduced odds of postoperative AKI after noncardiac surgery.

Study context

Population
Women >55 years and men >18 years undergoing noncardiac or cardiac surgery, Duke University Medical Center, 2013–2023 (excluding missing creatinine, CKD stage 5, transplant and minor cases)14,086 cardiac surgery
Participants
82,557 women
Exposure
Preoperative exogenous sex hormone therapy vs no sex hormone therapy
Outcome
Postoperative AKI (KDIGO serum creatinine criteria)
Methodological detailssingle-centre, multivariable logistic regression
  • Single-centre
  • Multivariable logistic regression

Main finding

As reported in the abstract

Postoperative AKI after noncardiac surgery
Each group vs no sex hormone therapyEstimate (95% CI)P value
Antiandrogensmen, noncardiac surgery
OR 0.83(0.72–0.96)
P < 0.01
Vaginal estrogenwomen, noncardiac surgery
aOR 0.61(0.47–0.79)
P < 0.001

Observational data: associations, not effects.

Further findings

Postoperative acute kidney injury (AKI) after cardiac surgery

Neither male nor female sex hormone exposures associated with AKI risk after cardiac surgery

Original publication

Retrospective Analysis of the Association of Preoperative Sex Hormone Therapy With the Development of Postoperative Acute Kidney Injury. Anesth Analg. Published 23 September 2025. doi:10.1213/ane.0000000000007727

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.